Co-Authors
This is a "connection" page, showing publications co-authored by Giulia Matusali and Silvia Meschi.
Connection Strength
0.808
-
SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus. Viruses. 2021 04 10; 13(4).
Score: 0.235
-
Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test. J Clin Virol. 2020 08; 129:104539.
Score: 0.223
-
Coordinate Induction of Humoral and Spike Specific T-Cell Response in a Cohort of Italian Health Care Workers Receiving BNT162b2 mRNA Vaccine. Microorganisms. 2021 Jun 16; 9(6).
Score: 0.059
-
Impact of Prior Influenza and Pneumoccocal Vaccines on Humoral and Cellular Response to SARS-CoV-2 BNT162b2 Vaccination. Vaccines (Basel). 2021 Jun 08; 9(6).
Score: 0.059
-
Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19. Mol Ther. 2021 08 04; 29(8):2412-2423.
Score: 0.059
-
Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis. Cell Death Dis. 2021 03 12; 12(3):263.
Score: 0.058
-
Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital. Int J Infect Dis. 2021 Apr; 105:532-539.
Score: 0.058
-
Virological Characterization of the First 2 COVID-19 Patients Diagnosed in Italy: Phylogenetic Analysis, Virus Shedding Profile From Different Body Sites, and Antibody Response Kinetics. Open Forum Infect Dis. 2020 Oct; 7(10):ofaa403.
Score: 0.056